Arthritis Res Ther. 2009;11(4):240. Epub 2009 Aug 19.

Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?

Source

Birmingham VA Medical Center, 700 19th St. S, Birmingham, AL 35233, USA. agaffo@uab.edu

Abstract

An association between high levels of serum urate and cardiovascular disease has been proposed for many decades. However, it was only recently that compelling basic science data, small clinical trials, and epidemiological studies have provided support to the idea of a true causal effect. In this review we present recently published data that study the association between hyperuricemia and selected cardiovascular diseases, with a final conclusion about the possibility of this association being causal.

PMID:: 19725932; [PubMed - indexed for MEDLINE]
PMCID: PMC2745789

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Uric Acid

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review [Uric acid and cardiorenal risk: marker or cause?]. [G Ital Nefrol. 2011]
Review [Uric acid and cardiorenal risk: marker or cause?].
Bellomo G, Venanzi S, Timio M. G Ital Nefrol. 2011 Mar-Apr; 28(2):157-65.
Review Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? [Curr Rheumatol Rep. 2010]
Review Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
Shah A, Keenan RT. Curr Rheumatol Rep. 2010 Apr; 12(2):118-24.
Review The role of hyperuricemia and gout in kidney and cardiovascular disease. [Cleve Clin J Med. 2008]
Review The role of hyperuricemia and gout in kidney and cardiovascular disease.
Edwards NL. Cleve Clin J Med. 2008 Jul; 75 Suppl 5:S13-6.
Review [Is hyperuricemia a cardiovascular risk factor?]. [Wiad Lek. 2006]
Review [Is hyperuricemia a cardiovascular risk factor?].
Chizyński K, Rózycka M. Wiad Lek. 2006; 59(5-6):364-7.
Review Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. [Am J Kidney Dis. 1999]
Review Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Am J Kidney Dis. 1999 Feb; 33(2):225-34.

See reviews... See all...

Cited by 3 PubMed Central articles

New and improved strategies for the treatment of gout. [Int J Nephrol Renovasc Dis. 2010]
New and improved strategies for the treatment of gout.
Dubchak N, Falasca GF. Int J Nephrol Renovasc Dis. 2010; 3:145-66. Epub 2010 Nov 24.
A young man with oligoarthritis: what is his cardiovascular risk? [Br J Gen Pract. 2010]
A young man with oligoarthritis: what is his cardiovascular risk?
Bolton E, Jordan K, Walker-Bone K. Br J Gen Pract. 2010 Dec; 60(581):913-5.
Review Uric acid transport and disease. [J Clin Invest. 2010]
Review Uric acid transport and disease.
So A, Thorens B. J Clin Invest. 2010 Jun; 120(6):1791-9. Epub 2010 Jun 1.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a...
Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
Arthritis Res Ther. 2009 ;11(4):240. Epub 2009 Aug 19 .

PubMed
TLR2 modulates inflammation in zymosan-induced arthritis in mice.
TLR2 modulates inflammation in zymosan-induced arthritis in mice.
Arthritis Res Ther. 2005 ;7(2):R370-9. Epub 2005 Jan 21 .

PubMed
Population-based epidemiology of intensive care: critical importance of ascertai...
Population-based epidemiology of intensive care: critical importance of ascertainment of residency status.
Crit Care. 2004 Dec ;8(6):R431-6. Epub 2004 Oct 15 .

PubMed
Treatment options in patients with rheumatoid arthritis failing initial TNF inhi...
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review.
Arthritis Res Ther. 2009 ;11 Suppl 1:S1. Epub 2009 Apr 6 .

PubMed
The scavenger receptor SR-A I/II (CD204) signals via the receptor tyrosine kinas...
The scavenger receptor SR-A I/II (CD204) signals via the receptor tyrosine kinase Mertk during apoptotic cell uptake by murine macrophages.
J Leukoc Biol. 2008 Aug ;84(2):510-8. Epub 2008 May 29 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: